AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bristol‑Myers Squibb Announces Dividend

September 11, 2019

NEW YORK--(BUSINESS WIRE)--Sep 11, 2019--

The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 1, 2019, to stockholders of record at the close of business on October 4, 2019.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable December 2, 2019 to stockholders of record at the close of business on November 5, 2019.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190911005721/en/

CONTACT: Media:

Carrie Fernandez, 609-252-5222,carrie.fernandez@bms.com

Investors:

Tim Power, 609-252-7509,timothy.power@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: ONCOLOGY HEALTH CLINICAL TRIALS PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2019.

PUB: 09/11/2019 04:16 PM/DISC: 09/11/2019 04:16 PM

http://www.businesswire.com/news/home/20190911005721/en

All contents © copyright 2019 The Associated Press. All rights reserved.